Laura Lee Sandler
Chief Operating Officer, Oruka Therapeutics, Inc.
Companies
- Oruka Therapeutics, Inc.Chief operating officer Jul 1, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Oruka Therapeutics, Inc. ORKA235,478 shares2$17.7M at $75.38Sep 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Sold 906 shares at $95.71 of Oruka Therapeutics, Inc.2
- Sep 1, 2026Sold 4,000 shares at $92.01 of Oruka Therapeutics, Inc.3
- Sep 1, 2026Sold 1,000 shares at $91.05 of Oruka Therapeutics, Inc.3
- Sep 1, 2026Exercised options 5,000 shares at $7.80 of Oruka Therapeutics, Inc.3
- Jul 1, 2026Sold 500 shares at $95.47 of Oruka Therapeutics, Inc.4
- Jul 1, 2026Sold 2,263 shares at $94.75 of Oruka Therapeutics, Inc.4
- Jul 1, 2026Sold 2,237 shares at $93.85 of Oruka Therapeutics, Inc.4
- Jul 1, 2026Exercised options 5,000 shares at $7.80 of Oruka Therapeutics, Inc.4
- Jun 15, 2026Sold 600 shares at $69.69 of Oruka Therapeutics, Inc.5
- May 1, 2026Sold 100 shares at $68.48 of Oruka Therapeutics, Inc.6
- May 1, 2026Sold 200 shares at $67.16 of Oruka Therapeutics, Inc.6
- May 1, 2026Sold 400 shares at $66.06 of Oruka Therapeutics, Inc.6
- May 1, 2026Sold 300 shares at $65.10 of Oruka Therapeutics, Inc.6
- May 1, 2026Sold 1,800 shares at $64.15 of Oruka Therapeutics, Inc.6
- May 1, 2026Sold 2,200 shares at $62.58 of Oruka Therapeutics, Inc.6
- May 1, 2026Exercised options 5,000 shares at $7.80 of Oruka Therapeutics, Inc.6
- Mar 16, 2026Sold 600 shares at $41.30 of Oruka Therapeutics, Inc.7
- Mar 2, 2026Sold 2,675 shares at $33.81 of Oruka Therapeutics, Inc.8
- Mar 2, 2026Sold 2,325 shares at $33.28 of Oruka Therapeutics, Inc.8
- Mar 2, 2026Exercised options 5,000 shares at $7.80 of Oruka Therapeutics, Inc.8
- Jan 23, 2026Granted 32,500 shares of Oruka Therapeutics, Inc.9
- Jan 2, 2026Sold 1,108 shares at $29.75 of Oruka Therapeutics, Inc.10
- Jan 2, 2026Sold 3,144 shares at $29.08 of Oruka Therapeutics, Inc.10
- Jan 2, 2026Sold 8,748 shares at $28.17 of Oruka Therapeutics, Inc.10
- Jan 2, 2026Exercised options 5,000 shares at $7.80 of Oruka Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Sep 1, 2026
- 4SEC EDGARForm 4 filed Jul 1, 2026
- 5SEC EDGARForm 4 filed Jun 15, 2026
- 6SEC EDGARForm 4 filed May 1, 2026
- 7SEC EDGARForm 4 filed Mar 17, 2026
- 8SEC EDGARForm 4 filed Mar 2, 2026
- 9SEC EDGARForm 4 filed Jan 23, 2026
- 10SEC EDGARForm 4 filed Jan 2, 2026